全文获取类型
收费全文 | 6535篇 |
免费 | 437篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 292篇 |
妇产科学 | 213篇 |
基础医学 | 1281篇 |
口腔科学 | 62篇 |
临床医学 | 622篇 |
内科学 | 1218篇 |
皮肤病学 | 168篇 |
神经病学 | 489篇 |
特种医学 | 290篇 |
外科学 | 846篇 |
综合类 | 41篇 |
预防医学 | 305篇 |
眼科学 | 179篇 |
药学 | 400篇 |
中国医学 | 5篇 |
肿瘤学 | 527篇 |
出版年
2022年 | 46篇 |
2021年 | 64篇 |
2020年 | 51篇 |
2019年 | 73篇 |
2018年 | 101篇 |
2017年 | 70篇 |
2016年 | 84篇 |
2015年 | 116篇 |
2014年 | 126篇 |
2013年 | 190篇 |
2012年 | 284篇 |
2011年 | 262篇 |
2010年 | 169篇 |
2009年 | 174篇 |
2008年 | 258篇 |
2007年 | 298篇 |
2006年 | 263篇 |
2005年 | 276篇 |
2004年 | 252篇 |
2003年 | 256篇 |
2002年 | 243篇 |
2001年 | 256篇 |
2000年 | 230篇 |
1999年 | 191篇 |
1998年 | 122篇 |
1997年 | 109篇 |
1996年 | 121篇 |
1995年 | 89篇 |
1994年 | 77篇 |
1993年 | 80篇 |
1992年 | 106篇 |
1991年 | 126篇 |
1990年 | 104篇 |
1989年 | 147篇 |
1988年 | 121篇 |
1987年 | 99篇 |
1986年 | 97篇 |
1985年 | 99篇 |
1984年 | 65篇 |
1983年 | 53篇 |
1979年 | 45篇 |
1978年 | 34篇 |
1976年 | 33篇 |
1975年 | 52篇 |
1974年 | 33篇 |
1972年 | 36篇 |
1936年 | 47篇 |
1935年 | 45篇 |
1933年 | 51篇 |
1932年 | 49篇 |
排序方式: 共有7011条查询结果,搜索用时 17 毫秒
991.
992.
993.
Stabile E Kinnaird T la Sala A Hanson SK Watkins C Campia U Shou M Zbinden S Fuchs S Kornfeld H Epstein SE Burnett MS 《Circulation》2006,113(1):118-124
994.
995.
996.
Sabharwal H Michon F Nelson D Dong W Fuchs K Manjarrez RC Sarkar A Uitz C Viteri-Jackson A Suarez RS Blake M Zabriskie JB 《The Journal of infectious diseases》2006,193(1):129-135
Previous studies have shown that human serum containing anti-group A streptococcus carbohydrate (GAS CHO) antibodies were opsonic for different M protein-carrying serotypes. To investigate the role that anti-GAS CHO antibodies play in passive and active protection, mice were immunized subcutaneously or intranasally with GAS CHO conjugated to tetanus toxoid, and mortality and oral colonization were monitored after challenge with live GAS. Compared with control mice, immunized mice were significantly protected against systemic or nasal challenge with GAS. Furthermore, studies of serum samples and throat cultures from Mexican children revealed an inverse relationship between high serum titers of anti-GAS CHO antibodies and the presence of GAS in the throat. Anti-GAS CHO antibodies were also tested for cross-reactivity with human tissues and cytoskeletal proteins. No cross-reactivity was observed in either assay. The present study demonstrates that GAS CHO is both immunogenic and protective against GAS infections. 相似文献
997.
Fuchs U Murray E Gueldner H Tenderich G Minami K Koerfer R 《Minerva cardioangiologica》2006,54(4):499-501
We report the case of a 56-year-old male heart transplant recipient, who underwent postoperative pacemaker implantation through a left sided superior vena cava (LSVC) via anonymous vein. We describe our successful management of this case. We suggest that the specific anatomic conditions should be considered in all heart transplant recipients with LSVC if pacemaker implantation is necessary postoperatively. 相似文献
998.
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations
下载免费PDF全文
![点击此处可从《The Journal of molecular diagnostics : JMD》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Ogino S Kawasaki T Kirkner GJ Loda M Fuchs CS 《The Journal of molecular diagnostics : JMD》2006,8(5):582-588
The CpG island methylator phenotype (CIMP or CIMP-high) with extensive promoter methylation seems to be a distinct epigenotype of colorectal cancer. However, no study has comprehensively examined features of colorectal cancer with less extensive promoter methylation (designated as "CIMP-low"). Using real-time polymerase chain reaction (MethyLight), we quantified DNA methylation in five CIMP-specific gene promoters [CACNA1G, CDKN2A (p16), CRABP1, MLH1, and NEUROG1] in 840 relatively unbiased, population-based colorectal cancer samples, obtained from two large prospective cohort studies. CIMP-low (defined as 1/5 to 3/5 methylated promoters) colorectal cancers were significantly more common among men (38 versus 30% in women, P = 0.01) and among KRAS-mutated tumors (44 versus 30% in KRAS/BRAF wild-type tumors, P = 0.0003; 19% in BRAF-mutated tumors, P < 0.0001). In addition, KRAS mutations were significantly more common in CIMP-low tumors (47%) than in CIMP-high tumors (with > or =4/5 methylated promoters, 12%, P < 0.0001) and CIMP-0 tumors (with 0/5 methylated promoters, 37%, P = 0.007). The associations of CIMP-low tumors with male sex and KRAS mutations still existed after tumors were stratified by microsatellite instability status. In conclusion, CIMP-low colorectal cancer is associated with male sex and KRAS mutations. The hypothesis that CIMP-low tumors are different from CIMP-high and CIMP-0 tumors needs to be tested further. 相似文献
999.
1000.
Kreitchmann R Canti I Gomes da Silva MM Barcelos N Fuchs SC 《Journal of acquired immune deficiency syndromes (1999)》2006,42(5):649; author reply 649-649; author reply 650